Chances are, if you’re reading this, you’ve heard a thing or two about the importance of sleep and how having a comfortable mattress is imperative in achieving a restful shut-eye. If your current mattress is not serving you for the better, we have good news. One of the best times of the year to find… Read More »
This article is brought to you by Specsavers. Has your family been complaining The Block’s too loud? Does everyone seem to be mumbling? Are you getting exhausted by brunch? Hearing loss is sneaky. It can creep up on you slowly but steadily, like scale on your houseplants – and the warning signs are easily missed.… Read More »
By Dr. Mercola Reaching puberty is a rite of passage that we’ve all been through, but children are now reaching it earlier than ever before, and while precocious puberty in girls has received most of the attention, we now know the trend applies to boys as well. In the 19th century, the onset of menstruation… Read More »
After Pfizer’s Ibrance failed a crucial study in HR-positive, HR-negative postsurgery breast cancer patients, the company clung to hope that it could still show a benefit in a high-risk subset of those patients. But new data have officially snuffed out those hopes. There’s “no saving adjuvant for Ibrance,” SVB Leerink analyst Geoffrey Porges wrote in… Read More »
With several new acute migraine treatments vying for market share, Eli Lilly is touting new data on Reyvow showing the med can provide patients “pain freedom” in as little as one hour, plus sustained relief for up to two days. In a phase 3 trial called Centurion, patients who took Lilly’s new drug at the 200mg dose were 4.6 times more likely to experience pain… Read More »